AMLX
AmylyxFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
AMLX vs peer average
30/100
AMLX vs. peer average (F vs. D)
Grade spread
A 1 · B 2 · C 1 · D 2 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AMPH is the first available peer comparator.
Amphastar is not a direct operating peer, but as a profitable specialty pharma it highlights that AMLX still carries materially higher binary development risk and weaker earnings support than more commercialized healthcare names.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AMLX
Amylyx
AMPH
Amphastar
Grade
F
B
Momentum
73
96
Value
41
69
Sentiment
14
40
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs AMPH
AMLX / AMPH
Grade Position
Below peers
AMLX vs. peer average (F vs. D)
30/100
Momentum
73
AMPHValue
41
AMPHSentiment
14
AMPHRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AMLX
AMPH is the first peer returned for this comparison set.